Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Liver Transplantation

  Free Subscription

Articles published in Hepatology

Retrieve available abstracts of 137 articles:
HTML format

Single Articles

    May 2020
  1. SOSA RA, Terry AQ, Kaldas FM, Jin YP, et al
    Disulfide-HMGB1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.
    Hepatology. 2020 May 19. doi: 10.1002/hep.31324.
    PubMed     Abstract available

  2. GABR A, Kulik L, Mouli S, Riaz A, et al
    Liver Transplantation Following Yttrium-90 Radioembolization: 15-year Experience in 207-Patient Cohort.
    Hepatology. 2020 May 16. doi: 10.1002/hep.31318.
    PubMed     Abstract available

    April 2020
  3. KUMAR A
    Letter to the Editor: Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?
    Hepatology. 2020 Apr 22. doi: 10.1002/hep.31285.
    PubMed     Abstract available

  4. KARDASHIAN A, Agopian V
    Reply to: "Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?"
    Hepatology. 2020 Apr 20. doi: 10.1002/hep.31283.
    PubMed     Abstract available

  5. FIX OK, Hameed B, Fontana RJ, Kwok RM, et al
    Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
    Hepatology. 2020 Apr 16. doi: 10.1002/hep.31281.
    PubMed     Abstract available

    March 2020
  6. QIN J, Wang H, Qin X, Zhang P, et al
    Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.
    Hepatology. 2020 Mar 27. doi: 10.1002/hep.31257.
    PubMed     Abstract available

  7. SCHWACHA-EIPPER B, Minciuna I, Banz V, Dufour JF, et al
    Immunotherapy as a downstaging therapy for liver transplantation.
    Hepatology. 2020 Mar 14. doi: 10.1002/hep.31234.
    PubMed     Abstract available

  8. KARDASHIAN A, Florman SS, Haydel B, Ruiz RM, et al
    Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Hepatology. 2020 Mar 2. doi: 10.1002/hep.31210.
    PubMed     Abstract available

    February 2020
  9. JUNGER H, Knoppke B, Weigand K, Evert K, et al
    Living donor liver transplantation from hepatitis C-infected donor to hepatitis C-infected recipient.
    Hepatology. 2020 Feb 17. doi: 10.1002/hep.31185.
    PubMed     Abstract available

  10. DEROO R, Trepo E, Holvoet T, De Pauw M, et al
    Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis.
    Hepatology. 2020 Feb 4. doi: 10.1002/hep.31164.
    PubMed     Abstract available

    January 2020
  11. WALLACE D, Cowling T, PcPhail MJ, Brown SE, et al
    Assessing the time-dependent impact of performance status on outcomes after liver transplantation.
    Hepatology. 2020 Jan 22. doi: 10.1002/hep.31124.
    PubMed     Abstract available

  12. KOLB JM, Conzen K, Wachs M, Crossno J Jr, et al
    Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
    Hepatology. 2020 Jan 14. doi: 10.1002/hep.31111.
    PubMed     Abstract available

    December 2019
  13. DERY KJ, Nakamura K, Kadono K, Hirao H, et al
    Human Antigen R (HuR): A New Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplant Injury.
    Hepatology. 2019 Dec 27. doi: 10.1002/hep.31093.
    PubMed     Abstract available

    Response to "Liver Transplantation for Acute Liver Failure Due to Dengue Fever" by Galante A et al. Hepatology. 2019;70:1863-65.
    Hepatology. 2019 Dec 17. doi: 10.1002/hep.31074.
    PubMed     Abstract available

    November 2019
  15. GYORI GP, Pereyra D, Rumpf B, Hackl H, et al
    Von Willebrand factor facilitates MELD-independent risk stratification on the waiting list for liver transplantation.
    Hepatology. 2019 Nov 27. doi: 10.1002/hep.31047.
    PubMed     Abstract available

  16. LEVITSKY J, Burrell BE, Kanaparthi S, Turka LA, et al
    Immunosuppression withdrawal in liver transplant recipients on sirolimus.
    Hepatology. 2019 Nov 13. doi: 10.1002/hep.31036.
    PubMed     Abstract available

  17. LEE BP, Vittinghoff E, Pletcher MJ, Dodge JL, et al
    Medicaid Policy and Liver Transplant for Alcohol-Related Liver Disease.
    Hepatology. 2019 Nov 8. doi: 10.1002/hep.31027.
    PubMed     Abstract available

  18. KUTKUT I, Rachwan RJ, Timsina LR, Ghabril MS, et al
    Pre-Liver Transplant Cardiac Catheterization is Associated with Low Rate of Myocardial Infarction and Cardiac Mortality.
    Hepatology. 2019 Nov 7. doi: 10.1002/hep.31023.
    PubMed     Abstract available

    October 2019
  19. POLI E, Kounis I, Guettier C, Verstuyft C, et al
    Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil.
    Hepatology. 2019 Oct 9. doi: 10.1002/hep.30984.
    PubMed     Abstract available

    September 2019
  20. SIDDIQUI MB, Siddiqui MS
    Reply letter for: HEP-18-1513.R3 - Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events In Liver Transplant Recipients.
    Hepatology. 2019 Sep 26. doi: 10.1002/hep.30971.
    PubMed     Abstract available

  21. WANG P, Zhong L
    Lipoproteins Sub-particles and Cardiovascular Risk In liver transplantation: More details, More Significance.
    Hepatology. 2019 Sep 26. doi: 10.1002/hep.30972.
    PubMed     Abstract available

  22. ASRANI SK, Jennings LW, Kim WR, Kamath P, et al
    MELD-GRAIL-Na: Glomerular filtration rate and mortality on Liver-Transplant Waiting List.
    Hepatology. 2019 Sep 16. doi: 10.1002/hep.30932.
    PubMed     Abstract available

  23. BI X, Deising A, Frenette C
    Acute Liver Failure from Exertional Heatstroke Can Result in Excellent Long-term Survival with Liver Transplantation.
    Hepatology. 2019 Sep 11. doi: 10.1002/hep.30938.
    PubMed     Abstract available

  24. LEVITSKY J, Asrani SK, Klintmalm G, Schiano T, et al
    Discovery and validation of a biomarker model (preserve) predictive of renal outcomes after liver transplantation.
    Hepatology. 2019 Sep 11. doi: 10.1002/hep.30939.
    PubMed     Abstract available

  25. LEE BP, Terrault NA
    Liver Transplantation in Unauthorized Immigrants in the United States.
    Hepatology. 2019 Sep 5. doi: 10.1002/hep.30926.
    PubMed     Abstract available

    August 2019
  26. KWON HM, Moon YJ, Jung KW, Park YS, et al
    Appraisal of cardiac ejection fraction with liver disease severity: Implication in post-liver transplantation mortality.
    Hepatology. 2019 Aug 28. doi: 10.1002/hep.30913.
    PubMed     Abstract available

    July 2019
  27. MEHTA N, Dodge JL, Grab JD, Yao FY, et al
    National Experience on Down-staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP, and Wait Time.
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30879.
    PubMed     Abstract available

  28. CASTELLOTE J, Mora Lujan JM, Riera-Mestre A
    mTOR-inhibitor-based immunosuppression following liver transplantation for Hereditary Hemorrhagic Telangiectasia.
    Hepatology. 2019 Jul 22. doi: 10.1002/hep.30870.
    PubMed     Abstract available

  29. CHOUDHARY NS, Saigal S, Soin AS
    Liver transplantation for Acute Liver Failure due to Dengue fever: first successful reported case worldwide.
    Hepatology. 2019 Jul 22. doi: 10.1002/hep.30869.
    PubMed     Abstract available

    Obesity and Liver Disease: The New Era of Liver Transplantation.
    Hepatology. 2019 Jul 13. doi: 10.1002/hep.30854.
    PubMed     Abstract available

    June 2019
  31. FIRL DJ, Sasaki K, Agopian VG, Gorgen A, et al
    Charting the Path Forward for Risk Prediction in Liver Transplant for HCC: International Validation of HALTHCC amongst 4,089 patients.
    Hepatology. 2019 Jun 27. doi: 10.1002/hep.30838.
    PubMed     Abstract available

  32. CAREY EJ, Lai JC, Sonnenday C, Tapper EB, et al
    A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30828.
    PubMed     Abstract available

  33. GALANTE A, Adeyi O, Lau L, Humar A, et al
    Liver transplantation for Acute Liver Failure due to Dengue fever: first successful reported case worldwide.
    Hepatology. 2019 Jun 4. doi: 10.1002/hep.30803.
    PubMed     Abstract available

    May 2019
  34. OEY RC, Spaander MCW, van Buuren HR, de Man RA, et al
    Screening colonoscopy in patients evaluated for liver transplantation: a closer look in a defined population.
    Hepatology. 2019 May 24. doi: 10.1002/hep.30781.
    PubMed     Abstract available

  35. MBACHI C, Abegunde AT
    Screening Colonoscopy in Patients Evaluated for Liver Transplant: Look before You Leap.
    Hepatology. 2019 May 23. doi: 10.1002/hep.30786.
    PubMed     Abstract available

  36. JIANG N, Li X, Xing YF, Qiao YD, et al
    Local regional therapy before liver transplantation for hepatocellular carcinoma.
    Hepatology. 2019 May 15. doi: 10.1002/hep.30769.
    PubMed     Abstract available

    April 2019
  37. LEVITSKY J, Asrani SK, Abecassis M, Ruiz R, et al
    External Validation of a Pre-Transplant Biomarker Model (REVERSE) Predictive of Renal Recovery after Liver Transplantation.
    Hepatology. 2019 Apr 19. doi: 10.1002/hep.30667.
    PubMed     Abstract available

    February 2019
  38. SINHA J, Mehta N, Dodge JL, Poltavskiy E, et al
    Are There Upper Limits in Tumor Burden for Down-staging of HCC to Liver Transplant? Analysis of the All-comers Protocol.
    Hepatology. 2019 Feb 19. doi: 10.1002/hep.30570.
    PubMed     Abstract available

  39. SCHLEGEL A, Dutkowski P
    Repair or Prevent - What is the real impact of normothermic machine perfusion in liver transplantation?
    Hepatology. 2019 Feb 17. doi: 10.1002/hep.30567.
    PubMed     Abstract available

  40. OEY RC, van Tilburg L, Erler NS, Metselaar HJ, et al
    The yield and safety of screening colonoscopy in patients evaluated for liver transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30562.
    PubMed     Abstract available

  41. CHIU V, Hogen R, Sher L, Wade N, et al
    Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30557.
    PubMed     Abstract available

    January 2019
  42. COTTER TG, Paul S, Sandikci B, Couri T, et al
    Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of HCV-Viremic Donors into HCV-Negative Recipients.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30540.
    PubMed     Abstract available

  43. SIDDIQUI MB, Arshad T, Patel S, Lee E, et al
    Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events In Liver Transplant Recipients.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30518.
    PubMed     Abstract available

    December 2018
  44. LEE BP, Vittinghoff E, Hsu C, Han H, et al
    Predicting Low-Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The SALT Score.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30478.
    PubMed     Abstract available

  45. RIVEIRO-BARCIELA M, Gironella M, Senin A, Salcedo MT, et al
    Decompensated liver disease due to primary hepatic amyloidosis: Is liver transplantation still mandatory?
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30464.
    PubMed     Abstract available

  46. DUMORTIER J, Dupuis-Girod S, Valette PJ, Valent A, et al
    Recurrence of hereditary hemorrhagic telangiectasia after liver transplantation: clinical implications and physiopathological insights.
    Hepatology. 2018 Dec 14. doi: 10.1002/hep.30424.
    PubMed     Abstract available

  47. RAND EB
    Cirrhotic Cardiomyopathy in children with BA: A new objective parameter to predict morbidity and mortality on the waitlist - and beyond!
    Hepatology. 2018 Dec 12. doi: 10.1002/hep.30419.
    PubMed     Abstract available

    November 2018
  48. MESZAROS M, Ursic-Bedoya J, Faure S, Pageaux GP, et al
    Immunosuppression minimization trials in liver transplantation: can we predict humoral response to asses eligibility?
    Hepatology. 2018 Nov 5. doi: 10.1002/hep.30345.
    PubMed     Abstract available

    October 2018
  49. BAJAJ JS, Moreau R, Kamath PS, Vargas HE, et al
    Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?
    Hepatology. 2018;68:1621-1632.
    PubMed     Abstract available

    September 2018
  50. JUCAUD V, Shaked A, DesMarais M, Sayre P, et al
    Prevalence and impact of de novo DSA during a multicenter immunosuppression withdrawal trial in adult liver transplant recipients.
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30281.
    PubMed     Abstract available

  51. COSTENTIN CE, Bababekov YJ, Zhu AX, Yeh H, et al
    Is it time to reconsider the Milan Criteria for selecting patients with hepatocellular carcinoma for deceased-donor liver transplantation?
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30278.
    PubMed     Abstract available

  52. SONG ATW, Abdala E, de Martino RB, Malbouisson LMS, et al
    Liver transplantation for fulminant hepatitis due to yellow fever.
    Hepatology. 2018 Sep 15. doi: 10.1002/hep.30273.
    PubMed     Abstract available

  53. RAEVENS S, Colle I
    Why pulse oximetry is inaccurate in liver cirrhosis - ancient knowledge.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30260.
    PubMed     Abstract available

  54. GE J, Gilroy R, Lai JC
    Receipt of a pediatric liver offer as the first offer reduces waitlist mortality for adult women.
    Hepatology. 2018;68:1101-1110.
    PubMed     Abstract available

    August 2018
  55. ALLEGRETTI AS, Parada XV, Ortiz GA, Long J, et al
    Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30230.
    PubMed     Abstract available

  56. GORGIS NM, Kennedy C, Lam F, Thompson K, et al
    Clinical Consequences of Cardiomyopathy in Children with Biliary Atresia Requiring Liver Transplantation.
    Hepatology. 2018 Aug 3. doi: 10.1002/hep.30204.
    PubMed     Abstract available

  57. FORDE KA, Fallon MB, Krowka MJ, Sprys M, et al
    Pulse Oximetry is Insensitive for Detection of Hepatopulmonary Syndrome in Patients evaluated for Liver Transplantation.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30139.
    PubMed     Abstract available

  58. SQUIRES JE, Rudnick DA, Hardison RM, Horslen S, et al
    Liver Transplant Listing in Pediatric Acute Liver Failure (PALF): Practices and Participant Characteristics.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30116.
    PubMed     Abstract available

  59. HUSSAINI T, Krajden M, Mitchell RA, Yoshida EM, et al
    Transplanting Hepatitis C seropositive, nucleic acid test negative donor organs into hepatitis C negative recipients.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30121.
    PubMed     Abstract available

    June 2018
    Transplantation of Livers from Viremic HCV Positive Donors into HCV Negative Recipients.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30106.

    May 2018
  61. FAN H, Zhu JH
    A novel frailty index improves risk prediction of waitlist mortality over the model for end-stage liver disease score alone.
    Hepatology. 2018;67:2059.

    April 2018
  62. CULLARO G, Park M, Lai JC
    "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients with Cirrhosis.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30058.
    PubMed     Abstract available

  63. OLORUNTOBA OO, Moylan CA
    "Too Female" for liver transplantation.
    Hepatology. 2018 Apr 20. doi: 10.1002/hep.30053.

  64. CHOLANKERIL G, Gadiparthi C, Kim D, Ahmed A, et al
    Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30043.

  65. KWONG AJ, Kim WR, Flemming JA
    De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30045.
    PubMed     Abstract available

  66. CHHATWAL J, Bethea ED, Samur S, Chung RT, et al
    Reply to Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30042.

  67. REAU N, Kwo PY, Rhee S, Brown RS Jr., et al
    Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30046.
    PubMed     Abstract available

  68. IZZY M, Oh J, Watt KD
    Cirrhotic cardiomyopathy after transplantation: Neither the transient nor innocent bystander.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30040.
    PubMed     Abstract available

  69. HOUSSEL-DEBRY P, Coilly A, Fougerou-Leurent C, Jezequel C, et al
    12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29918.
    PubMed     Abstract available

  70. MARRERO JA, Kulik LM, Sirlin C, Zhu AX, et al
    Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29913.

    March 2018
  71. FIRL DJ, Kimura S, McVey J, Hashimoto K, et al
    Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with HALTHCC improves ablate and wait strategy.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29907.
    PubMed     Abstract available

  72. YANG MQ, Du Q, Goswami J, Varley PR, et al
    Interferon regulatory factor 1-Rab27a regulated extracellular vesicles promote liver ischemia/reperfusion injury.
    Hepatology. 2018;67:1056-1070.
    PubMed     Abstract available

    February 2018
  73. WU JF, Lee CS, Lin WH, Jeng YM, et al
    Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29856.
    PubMed     Abstract available

  74. HUANG AC, Mehta N, Dodge JL, Yao FY, et al
    Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
    Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
    PubMed     Abstract available

  75. ZAMORA-VALDES D, Watt KD, Kellogg TA, Poterucha JJ, et al
    Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29848.
    PubMed     Abstract available

  76. MAZZAFERRO V, Droz Dit Busset M, Bhoori S
    Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better.
    Hepatology. 2018 Feb 9. doi: 10.1002/hep.29835.

  77. ATKINSON SR, McQuillin A, Morgan MY, Thursz MR, et al
    People who survive an episode of severe alcoholic hepatitis should be advised to maintain total abstinence from alcohol.
    Hepatology. 2018 Feb 2. doi: 10.1002/hep.29825.

    January 2018
  78. MARTINI S, Caccamo L, Rizzetto M
    Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D?
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29796.

  79. KAGEYAMA S, Nakamura K, Fujii T, Ke B, et al
    Recombinant Relaxin Protects Liver Transplants from Ischemia Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29787.
    PubMed     Abstract available

  80. CHALASANI N, Younossi Z, Lavine JE, Charlton M, et al
    The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Hepatology. 2018;67:328-357.

    December 2017
  81. WINTER A, Daures JP, Landais P
    Intention-to-treat survival benefit in liver transplantation: comments on Lai et al.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29755.

  82. CHHATWAL J, Samur S, Bethea ED, Ayer T, et al
    Transplanting HCV-positive livers into HCV-negative patients with preemptive antiviral treatment: A modeling study.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29723.
    PubMed     Abstract available

  83. YOUNOSSI ZM, Loomba R, Rinella ME, Bugianesi E, et al
    Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29724.
    PubMed     Abstract available

  84. KAKABADZE Z, Kakabadze A, Chakhunashvili D, Karalashvili L, et al
    Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29713.
    PubMed     Abstract available

  85. BARI K, Luckett K, Kaiser T, Diwan T, et al
    Hepatitis C Transmission from Seropositive, Non-Viremic Donors to Non-Hepatitis C Liver Transplant Recipients.
    Hepatology. 2017 Dec 2. doi: 10.1002/hep.29704.
    PubMed     Abstract available

    November 2017
  86. JARAMILLO-CALLE DA, Castano Quintero O, Marin JI, Cock-Rada AM, et al
    Is liver transplantation for intractable attacks of porphyria a viable treatment in a developing country?
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29650.

    October 2017
  87. YANG JD, Mannalithara A, Piscitello AJ, Kisiel JB, et al
    Impact of Surveillance for Hepatocellular Carcinoma on Survival in Patients with Compensated Cirrhosis.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29594.
    PubMed     Abstract available

  88. RAMMOHAN A, Reddy MS, Farouk M, Vargese J, et al
    Pembrolizumab for Metastatic Hepatocellular Carcinoma Following Live Donor Liver Transplantation: The Silver Bullet?
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29575.
    PubMed     Abstract available

  89. GONZALEZ SA, Trotter JF
    The Rise of the Opioid Epidemic and Hepatitis C Positive Organs: A New Era in Liver Transplantation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29572.
    PubMed     Abstract available

  90. MONTANO-LOZA AJ, Mazurak VC, Ebadi M, Meza-Junco J, et al
    Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29578.
    PubMed     Abstract available

  91. BARBIER L, Ronot M, Aussilhou B, Cauchy F, et al
    Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29582.
    PubMed     Abstract available

    September 2017
  92. LIU X, Elmofti Y, Kulaga C, Gisi B, et al
    Societal perspectives' analysis for evaluating direct-acting antivirals affordability while awaiting liver transplant.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29558.

  93. MAURO E, Crespo G, Montironi C, Londono MC, et al
    Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after SVR in recurrent hepatitis C.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29557.
    PubMed     Abstract available

  94. ONO Y, Perez-Gutierrez A, Nakao T, Dai H, et al
    Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate anti-donor T cell responses in mouse liver transplant tolerance.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29529.
    PubMed     Abstract available

  95. VIONNET J, Pascual M, Testoni B, Combet C, et al
    Late hepatitis B reactivation following DAA-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29528.

  96. VANWAGNER LB, Ning H, Whitsett M, Levitsky J, et al
    In Reply To: Xue et al. "Developing a Prediction Model for Cardiovascular Risk after Orthotopic Liver Transplantation".
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29525.

  97. XUE FS, Liu YY, Yang GZ
    Developing a Prediction Model for Cardiovascular Risk after Orthotopic Liver Transplantation.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29527.

  98. MARSHALL K, Jin J, Atkinson C, Alawieh A, et al
    Natural IgM initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29512.
    PubMed     Abstract available

    August 2017
  99. KULIK L, Heimbach JK, Zaiem F, Almasri J, et al
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29485.
    PubMed     Abstract available

  100. PARIKH ND, Marrero WJ, Wang J, Steuer J, et al
    Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29473.
    PubMed     Abstract available

  101. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Abstract available

  102. LAI JC, Covinsky KE, Dodge JL, Boscardin WJ, et al
    Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Hepatology. 2017;66:564-574.
    PubMed     Abstract available

  103. AZOULAY D, Lahat E, Salloum C, Compagnon P, et al
    Heterotopic liver retransplantation for impossible former graft explantation.
    Hepatology. 2017;66:655-657.

    July 2017
  104. GU J, Jeong S, Xia Q
    Intrahepatic cholangiocarcinoma arising from HBV Infection may be a highly selected population for liver transplantation.
    Hepatology. 2017 Jul 31. doi: 10.1002/hep.29413.

  105. LUCEY MR
    Redefining successful treatment of severe alcoholic hepatitis.
    Hepatology. 2017 Jul 24. doi: 10.1002/hep.29398.

  106. VANWAGNER LB, Ning H, Whitsett M, Levitsky J, et al
    A Point-based Prediction Model for Cardiovascular Risk in Orthotopic Liver Transplantation: The CAR-OLT Score.
    Hepatology. 2017 Jul 13. doi: 10.1002/hep.29329.
    PubMed     Abstract available

  107. CARDOSO FS, Pereira R, Alexandrino G, Bagulho L, et al
    Futility of care in patients with acute-on-chronic liver failure.
    Hepatology. 2017;66:292-294.

    June 2017
  108. LAI Q, Vitale A, Iesari S, Finkenstedt A, et al
    Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29342.
    PubMed     Abstract available

  109. KWONG AJ, Goel A, Mannalithara A, Kim WR, et al
    Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29301.
    PubMed     Abstract available

    May 2017
  110. GANE E
    Is HBIG still needed after liver transplantation for CHB?
    Hepatology. 2017 May 26. doi: 10.1002/hep.29292.

  111. HAYASHI PH, Rockey D, Fontana RJ, Tillmann HL, et al
    Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29283.
    PubMed     Abstract available

  112. SAMOYLOVA ML, Nigrini MJ, Dodge JL, Roberts JP, et al
    Biases in the reporting of hcc tumor sizes on the liver transplant waiting list.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29269.
    PubMed     Abstract available

  113. SAXENA V, Khungar V, Verna EC, Levitsky J, et al
    Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29258.
    PubMed     Abstract available

    April 2017
  114. DENEAU MR, El-Matary W, Valentino PL, Abdou R, et al
    The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
    Hepatology. 2017 Apr 8. doi: 10.1002/hep.29204.
    PubMed     Abstract available

    March 2017
  115. FUNG J, Wong T, Chok K, Chan A, et al
    Long Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B after Liver Transplantation: Results up to 8 years.
    Hepatology. 2017 Mar 31. doi: 10.1002/hep.29191.
    PubMed     Abstract available

  116. AHMED A, Gonzalez SA, Cholankeril G, Perumpail RB, et al
    Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29137.
    PubMed     Abstract available

  117. ALONSO EM, Horslen SP, Behrens EM, Doo E, et al
    Pediatric acute liver failure of undetermined cause: A research workshop.
    Hepatology. 2017;65:1026-1037.
    PubMed     Abstract available

    February 2017
  118. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Abstract available

  119. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Abstract available

    January 2017
  120. BOYD A, Miailhes P, Lacombe K, Zoulim F, et al
    Potential effect of lamivudine-induced S-gene mutations on liver-related pathogenesis in hepatitis D virus infection.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29062.

  121. VERNA EC
    The Dynamic Landscape of Liver Transplant in the Era of Effective HCV Therapy.
    Hepatology. 2017 Jan 17. doi: 10.1002/hep.29054.

  122. SHAKED A, Chang BL, Barnes MR, Sayre P, et al
    An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Hepatology. 2017;65:269-280.
    PubMed     Abstract available

    An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Hepatology. 2017;65:15-17.

    December 2016
  124. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.

  125. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Abstract available

  126. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.

  127. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.

  128. MARTINI S, Salizzoni M, David E, Tandoi F, et al
    Favorable short-term outcome of HCV-positive liver graft with bridging fibrosis: A plea for very early viral eradication.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28978.
    PubMed     Abstract available

    November 2016
  129. DE VRIES EM, de Krijger M, Farkkila M, Arola J, et al
    Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis; An International Cohort Study.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28963.
    PubMed     Abstract available

  130. CHHATWAL J, Samur S, Kues B, Ayer T, et al
    Optimal Timing of Hepatitis C Treatment for Patients on the Liver Transplant Waiting List.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28926.
    PubMed     Abstract available

  131. FLEMMING JA, Kim WR, Brosgart CL, Terrault NA, et al
    Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28923.
    PubMed     Abstract available

    October 2016
  132. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Abstract available

  133. EMOND JC, Griesemer AD
    Tolerance in clinical liver transplantation: The long road ahead.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28862.

    September 2016
    The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28841.

    August 2016
  135. TAWAR RG, Heydmann L, Bach C, Schuttrumpf J, et al
    Broad neutralization of hepatitis C virus resistant variants by Civacir(R) hepatitis C immune globulin.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28767.
    PubMed     Abstract available

    July 2016
  136. LANGBERG KM, Taddei TH
    Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28717.

    March 2016
  137. FRIEDRICH K, Smit M, Brune M, Giese T, et al
    CD14 is associated with biliary stricture formation.
    Hepatology. 2016 Mar 11. doi: 10.1002/hep.28543.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.